Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1988 Jun;51(6):767–772. doi: 10.1136/jnnp.51.6.767

Blepharospasm: a review of 264 patients.

F Grandas 1, J Elston 1, N Quinn 1, C D Marsden 1
PMCID: PMC1033145  PMID: 3404184

Abstract

The natural history and response to different treatments have been evaluated in 264 patients with blepharospasm. The mean age of onset was 55.8 years and there was a female preponderance of 1.8 to 1. Dystonia elsewhere was found in 78% of patients, usually in the cranial-cervical region, and appeared to follow a somatotopic progression. A family history of blepharospasm or dystonia elsewhere was found in 9.5% of cases, which suggests a genetic predisposition. Ocular lesions preceded the onset of blepharospasm in 12.1% of cases. The response to drugs was inconsistent, although initial improvement was experienced by one fifth of patients treated with anticholinergics. Twenty-nine bilateral facial nerve avulsion operations were performed with benefit in 27 cases; but recurrences appeared in 22, on average one year after surgery. Botulinum toxin injections were performed in 151 patients. Significant improvement was achieved in 118 cases. Mean duration of benefit was 9.2 weeks. Transient ptosis and diplopia were the commonest side effects.

Full text

PDF
767

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Altrocchi P. H., Forno L. S. Spontaneous oral-facial dyskinesia: neuropathology of a case. Neurology. 1983 Jun;33(6):802–805. doi: 10.1212/wnl.33.6.802. [DOI] [PubMed] [Google Scholar]
  2. Berardelli A., Rothwell J. C., Day B. L., Marsden C. D. Pathophysiology of blepharospasm and oromandibular dystonia. Brain. 1985 Sep;108(Pt 3):593–608. doi: 10.1093/brain/108.3.593. [DOI] [PubMed] [Google Scholar]
  3. Blepharospasm associated with palatal myoclonus and communicating hydrocephalus. Neurology. 1984 Nov;34(11):1522–1524. [PubMed] [Google Scholar]
  4. Burke R. E., Fahn S., Jankovic J., Marsden C. D., Lang A. E., Gollomp S., Ilson J. Tardive dystonia: late-onset and persistent dystonia caused by antipsychotic drugs. Neurology. 1982 Dec;32(12):1335–1346. doi: 10.1212/wnl.32.12.1335. [DOI] [PubMed] [Google Scholar]
  5. Casey D. E. Pharmacology of blepharospasm-oromandibular dystonia syndrome. Neurology. 1980 Jul;30(7 Pt 1):690–695. doi: 10.1212/wnl.30.7.690. [DOI] [PubMed] [Google Scholar]
  6. Chakravorty N. K. Treatment of blepharospasm with levodopa. Postgrad Med J. 1974 Aug;50(586):521–523. doi: 10.1136/pgmj.50.586.521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Corin M. S., Elizan T. S., Bender M. B. Oculomotor function in patients with Parkinson's disease. J Neurol Sci. 1972 Mar;15(3):251–265. doi: 10.1016/0022-510x(72)90068-8. [DOI] [PubMed] [Google Scholar]
  8. Day T. J., Lefroy R. B., Mastaglia F. L. Meige's syndrome and palatal myoclonus associated with brain stem stroke. A common mechanism? J Neurol Neurosurg Psychiatry. 1986 Nov;49(11):1324–1325. doi: 10.1136/jnnp.49.11.1324. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Dolly J. O., Black J., Williams R. S., Melling J. Acceptors for botulinum neurotoxin reside on motor nerve terminals and mediate its internalization. Nature. 1984 Feb 2;307(5950):457–460. doi: 10.1038/307457a0. [DOI] [PubMed] [Google Scholar]
  10. Dutton J. J., Buckley E. G. Botulinum toxin in the management of blepharospasm. Arch Neurol. 1986 Apr;43(4):380–382. doi: 10.1001/archneur.1986.00520040060020. [DOI] [PubMed] [Google Scholar]
  11. Duvoisin R. C. Meige syndrome: relief on high-dose anticholinergic therapy. Clin Neuropharmacol. 1983 Mar;6(1):63–66. [PubMed] [Google Scholar]
  12. Elston J. S., Russell R. W. Effect of treatment with botulinum toxin on neurogenic blepharospasm. Br Med J (Clin Res Ed) 1985 Jun 22;290(6485):1857–1859. doi: 10.1136/bmj.290.6485.1857. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Fahn S. High dosage anticholinergic therapy in dystonia. Neurology. 1983 Oct;33(10):1255–1261. doi: 10.1212/wnl.33.10.1255. [DOI] [PubMed] [Google Scholar]
  14. Frueh B. R., Felt D. P., Wojno T. H., Musch D. C. Treatment of blepharospasm with botulinum toxin. A preliminary report. Arch Ophthalmol. 1984 Oct;102(10):1464–1468. doi: 10.1001/archopht.1984.01040031184014. [DOI] [PubMed] [Google Scholar]
  15. García-Albea E., Franch O., Muñoz D., Ricoy J. R. Brueghel's syndrome, report of a case with postmortem studies. J Neurol Neurosurg Psychiatry. 1981 May;44(5):437–440. doi: 10.1136/jnnp.44.5.437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Gillum W. N., Anderson R. L. Blepharospasm surgery. An anatomical approach. Arch Ophthalmol. 1981 Jun;99(6):1056–1062. doi: 10.1001/archopht.1981.03930011056015. [DOI] [PubMed] [Google Scholar]
  17. Jackson J. A., Jankovic J., Ford J. Progressive supranuclear palsy: clinical features and response to treatment in 16 patients. Ann Neurol. 1983 Mar;13(3):273–278. doi: 10.1002/ana.410130308. [DOI] [PubMed] [Google Scholar]
  18. Jankovic J. Blepharospasm with basal ganglia lesions. Arch Neurol. 1986 Sep;43(9):866–868. doi: 10.1001/archneur.1986.00520090006004. [DOI] [PubMed] [Google Scholar]
  19. Jankovic J., Ford J. Blepharospasm and orofacial-cervical dystonia: clinical and pharmacological findings in 100 patients. Ann Neurol. 1983 Apr;13(4):402–411. doi: 10.1002/ana.410130406. [DOI] [PubMed] [Google Scholar]
  20. Jankovic J., Havins W. E., Wilkins R. B. Blinking and blepharospasm. Mechanism, diagnosis, and management. JAMA. 1982 Dec 17;248(23):3160–3164. [PubMed] [Google Scholar]
  21. Jankovic J., Orman J. Blepharospasm: demographic and clinical survey of 250 patients. Ann Ophthalmol. 1984 Apr;16(4):371–376. [PubMed] [Google Scholar]
  22. Jankovic J., Patel S. C. Blepharospasm associated with brainstem lesions. Neurology. 1983 Sep;33(9):1237–1240. doi: 10.1212/wnl.33.9.1237. [DOI] [PubMed] [Google Scholar]
  23. Jankovic J. Treatment of hyperkinetic movement disorders with tetrabenazine: a double-blind crossover study. Ann Neurol. 1982 Jan;11(1):41–47. doi: 10.1002/ana.410110108. [DOI] [PubMed] [Google Scholar]
  24. Kao I., Drachman D. B., Price D. L. Botulinum toxin: mechanism of presynaptic blockade. Science. 1976 Sep 24;193(4259):1256–1258. doi: 10.1126/science.785600. [DOI] [PubMed] [Google Scholar]
  25. Keane J. R., Young J. A. Blepharospasm with bilateral basal ganglia infarction. Arch Neurol. 1985 Dec;42(12):1206–1208. doi: 10.1001/archneur.1985.04060110088025. [DOI] [PubMed] [Google Scholar]
  26. Klawans H. L., Jr, Erlich M. A. Observations on the mechanism of parkinsonian blepharospasm and its treatment with L-dopa. Eur Neurol. 1970;3(6):365–372. doi: 10.1159/000113999. [DOI] [PubMed] [Google Scholar]
  27. Lang A. E. High dose anticholinergic therapy in adult dystonia. Can J Neurol Sci. 1986 Feb;13(1):42–46. doi: 10.1017/s0317167100035770. [DOI] [PubMed] [Google Scholar]
  28. Leenders K. L., Frackowiak R. S., Quinn N., Brooks D., Sumner D., Marsden C. D. Ipsilateral blepharospasm and contralateral hemidystonia and parkinsonism in a patient with a unilateral rostral brainstem-thalamic lesion: structural and functional abnormalities studied with CT, MRI, and PET scanning. Mov Disord. 1986;1(1):51–58. doi: 10.1002/mds.870010107. [DOI] [PubMed] [Google Scholar]
  29. Marsden C. D. Blepharospasm-oromandibular dystonia syndrome (Brueghel's syndrome). A variant of adult-onset torsion dystonia? J Neurol Neurosurg Psychiatry. 1976 Dec;39(12):1204–1209. doi: 10.1136/jnnp.39.12.1204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Marsden C. D., Lang A. E., Sheehy M. P. Pharmacology of cranial dystonia. Neurology. 1983 Aug;33(8):1100–1102. doi: 10.1212/wnl.33.8.1100. [DOI] [PubMed] [Google Scholar]
  31. Marsden C. D. The problem of adult-onset idiopathic torsion dystonia and other isolated dyskinesias in adult life (including blepharospasm, oromandibular dystonia, dystonic writer's cramp, and torticollis, or axial dystonia). Adv Neurol. 1976;14:259–276. [PubMed] [Google Scholar]
  32. Mauriello J. A., Jr Blepharospasm, Meige syndrome, and hemifacial spasm: treatment with botulinum toxin. Neurology. 1985 Oct;35(10):1499–1500. doi: 10.1212/wnl.35.10.1499. [DOI] [PubMed] [Google Scholar]
  33. McCord C. D., Jr, Coles W. H., Shore J. W., Spector R., Putnam J. R. Treatment of essential blepharospasm. I. Comparison of facial nerve avulsion and eyebrow-eyelid muscle stripping procedure. Arch Ophthalmol. 1984 Feb;102(2):266–268. doi: 10.1001/archopht.1984.01040030216030. [DOI] [PubMed] [Google Scholar]
  34. McCord C. D., Jr, Shore J., Putnam J. R. Treatment of essential blepharospasm. II. A modification of exposure for the muscle stripping technique. Arch Ophthalmol. 1984 Feb;102(2):269–273. doi: 10.1001/archopht.1984.01040030219031. [DOI] [PubMed] [Google Scholar]
  35. Merikangas J. R., Reynolds C. F., 3rd Blepharospasm: successful treatment with clonazepam. Ann Neurol. 1979 Apr;5(4):401–402. doi: 10.1002/ana.410050418. [DOI] [PubMed] [Google Scholar]
  36. Micheli F., Fernández Pardal M. M., Leiguarda R. C. Beneficial effects of lisuride in Meige disease. Neurology. 1982 Apr;32(4):432–434. doi: 10.1212/wnl.32.4.432. [DOI] [PubMed] [Google Scholar]
  37. Miller E. Dimethyl aminoethanol in the treatment of blepharospasm. N Engl J Med. 1973 Sep 27;289(13):697–697. doi: 10.1056/nejm197309272891320. [DOI] [PubMed] [Google Scholar]
  38. Nutt J. G., Hammerstad J. P. Blepharospasm and oromandibular dystonia (Meige's syndrome) in sisters. Ann Neurol. 1981 Feb;9(2):189–191. doi: 10.1002/ana.410090214. [DOI] [PubMed] [Google Scholar]
  39. Nutt J. G., Hammerstad J. P., deGarmo P., Carter J. Cranial dystonia: double-blind crossover study of anticholinergics. Neurology. 1984 Feb;34(2):215–217. doi: 10.1212/wnl.34.2.215. [DOI] [PubMed] [Google Scholar]
  40. Paulson G. W. Meige's syndrome. Dyskinesia of the eyelids and facial muscles. Geriatrics. 1972 Aug;27(8):69–73. [PubMed] [Google Scholar]
  41. Powers J. M. Blepharospasm due to unilateral diencephalon infarction. Neurology. 1985 Feb;35(2):283–284. doi: 10.1212/wnl.35.2.283-b. [DOI] [PubMed] [Google Scholar]
  42. Powers J. M. Decongestant-induced blepharospasm and orofacial dystonia. JAMA. 1982 Jun 18;247(23):3244–3245. [PubMed] [Google Scholar]
  43. Schott G. D. The relationship of peripheral trauma and pain to dystonia. J Neurol Neurosurg Psychiatry. 1985 Jul;48(7):698–701. doi: 10.1136/jnnp.48.7.698. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Scott A. B., Kennedy R. A., Stubbs H. A. Botulinum A toxin injection as a treatment for blepharospasm. Arch Ophthalmol. 1985 Mar;103(3):347–350. doi: 10.1001/archopht.1985.01050030043017. [DOI] [PubMed] [Google Scholar]
  45. Sheehy M. P., Marsden C. D. Trauma and pain in spasmodic torticollis. Lancet. 1980 Apr 5;1(8171):777–778. doi: 10.1016/s0140-6736(80)91281-7. [DOI] [PubMed] [Google Scholar]
  46. Sheehy M. P., Marsden C. D. Writers' cramp-a focal dystonia. Brain. 1982 Sep;105(Pt 3):461–480. doi: 10.1093/brain/105.3.461. [DOI] [PubMed] [Google Scholar]
  47. Skarf B., Sharpe J. A. Choline for blepharospasm. N Engl J Med. 1981 Oct 15;305(16):957–958. [PubMed] [Google Scholar]
  48. Tanner C. M., Glantz R. H., Klawans H. L. Meige disease: acute and chronic cholinergic effects. Neurology. 1982 Jul;32(7):783–785. doi: 10.1212/wnl.32.7.783. [DOI] [PubMed] [Google Scholar]
  49. Tolosa E. S. Clinical features of Meige's disease (idiopathic orofacial dystonia): a report of 17 cases. Arch Neurol. 1981 Mar;38(3):147–151. doi: 10.1001/archneur.1981.00510030041005. [DOI] [PubMed] [Google Scholar]
  50. Tolosa E. S., Lai C. Meige disease: striatal dopaminergic preponderance. Neurology. 1979 Aug;29(8):1126–1130. doi: 10.1212/wnl.29.8.1126. [DOI] [PubMed] [Google Scholar]
  51. Tsoy E. A., Buckley E. G., Dutton J. J. Treatment of blepharospasm with botulinum toxin. Am J Ophthalmol. 1985 Feb 15;99(2):176–179. doi: 10.1016/0002-9394(85)90228-4. [DOI] [PubMed] [Google Scholar]
  52. Weiner W. J., Nausieda P. A., Glantz R. H. Meige syndrome (blepharospasm-oromandibular dystonia) after long-term neuroleptic therapy. Neurology. 1981 Dec;31(12):1555–1556. doi: 10.1212/wnl.31.12.1555. [DOI] [PubMed] [Google Scholar]
  53. Weiner W. J., Nausieda P. A. Meige's syndrome during long-term dopaminergic therapy in Parkinson's disease. Arch Neurol. 1982 Jul;39(7):451–452. doi: 10.1001/archneur.1982.00510190069027. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES